This PR publication and distribution service is an immediate way to place your news in front of BioInformant’s traffic of nearly one million readers per year.
Do you have a press announcement that is relevant to the cell therapy industry? If you are an avid reader of BioInformant and it is relevant to our readers who follow us for cell therapy industry news, then we would be honored to get it industry-wide attention.
As reported by Google Analytics, BioInformant.com attracts over 68,000+ unique viewers per month per year, which is nearly one million views per year.
We will leverage for you the same strategies and distribution channels that have grown BioInformant into the world’s largest publisher of stem cell industry news.
These audience channels are how you came to know about us, so we are confident that we can get industry-wide recognition for you too.
Access BioInformant’s Targeted Audience
When you partner with us, we publish your announcement to BioInformant.com to reach our online readers and distribute it across all of our other audience channels as well.
These audience channels include:
- Online readers of BioInformant.com (Nearly one million viewers per year)
- Search Engine Optimization (SEO) to drive daily Google traffic
- 31,8000+ LinkedIn followers
- 19,700+ Twitter followers
- 4,100+ Facebook followers
- 175,000+ Members of LinkedIn Groups
- 11.300+ Push Notification Subscribers
- 45,500+ Email Subscribers
BioInformant’s Strategic Distribution
One of BioInformant’s strengths is that we are experts at digital marketing. It is how we grew our site from no traffic to nearly a million views per year.
As mentioned above, we will feature your press release in our Email Newsletter to 45,000+ cell therapy industry subscribers. This will get it targeted visibility by delivering your news to the inbox of stem cell industry participants worldwide.
We control hundreds of stem cell terms on Google (1st page results) using Search Engine Optimization (SEO) techniques, so we also optimize your announcement to rank it highly within Google Search results. This drives continuous, daily traffic, positioning your news release to act as an evergreen asset.
We also feature it using Push Notifications sent to over 9,100+ subscribers. These are slide-in notifications that appear in the bottom right of a user’s screens/devices when new content goes live on the BioInformant website.
In addition to leveraging our own audience channels, we will post your announcement to targeted LinkedIn Groups to reach another 175,000+ readers, including:
- Biotech & Pharma Professionals Network (89,965 members)
- Biotechnology/Pharmaceuticals – 61,576 members
- Clinical Development and Innovation (13,900 Members)
- Regenerative Medicine Group – 6,400 Members
- Stem Cells and Regenerative Medicine (3,800 Members)
- And many more
Because our Founder, Cade Hildreth, B.A., M.S., in a Top Contributor to numerous LinkedIn groups, our posts often get emailed out by LinkedIn to all group members. It is also valuable to have a third-party share the content on your behalf, because it builds credibility in comparison to posting it yourself.
Immediate Industry-Wide Recognition
These are the same strategies and distribution channels that we used to grow BioInformant into the world’s largest publisher of stem cell industry news in a brief period of time.
For this reason, we are confident we can get your industry-wide attention too. Click here to see press announcements for company leaders we represent across the stem cell industry or view Client Testimonials.
For a limited-time, this service is available for only $297 (25% off). Get your announcement immediate visibility by tapping into BioInformant’s large and targeted audience.
To partner with us for distribution of your announcement, checkout below and send your press release to our team at Info@BioInformant.com.